SSA
COEPW

Schonfeld Strategic Advisors’s Coeptis Therapeutics Warrants COEPW Stock Holding History

Schonfeld Strategic Advisors’s Portfolio COEPW Stock Details COEPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,806
Closed -$1.08K – 2172
2022
Q4 		$1.08K Buy
+10,806
New +$722 ﹤0.01% 2459
2022
Q3 		– Sell
-11,406
Closed -$1K – 2984
2022
Q2 		$1K Buy
+11,406
New +$857 ﹤0.01% 2432

Other funds holding COEPW

ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Schonfeld Strategic Advisors's COEPW Position: Q1 2023 in Review

Schonfeld Strategic Advisors sold out of Coeptis Therapeutics Warrants (COEPW) in Q1 2023, closing a stake of 10,806 shares — an estimated $1.08K sold.

Schonfeld Strategic Advisors first reported a position in COEPW in Q2 2022 and held it in 2 quarters. The position peaked at $1.08K in Q4 2022. 18 funds tracked by Wall St. Rank hold COEPW as of Q1 2023.

  • Schonfeld Strategic Advisors reported no remaining Coeptis Therapeutics Warrants position as of Q1 2023 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 10,806 Coeptis Therapeutics Warrants shares in Q1 2023, an estimated $1.08K.
  • Schonfeld Strategic Advisors first reported a position in Coeptis Therapeutics Warrants in Q2 2022 and held it in 2 quarters.
  • Schonfeld Strategic Advisors's Coeptis Therapeutics Warrants position peaked at $1.08K in Q4 2022.
  • 18 funds tracked by Wall St. Rank held Coeptis Therapeutics Warrants as of Q1 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2023, filed 15 May 2023.